FLT1 and chronic obstructive pulmonary disease: In addition, quantification in immunohistochemical analysis, the untreated COPD group showed a higher expression level of VEGFR1 than did the normal and sunitinib administrated groups (Fig. 4B, P = 0.000 < 0.01), in which the sunitinib treated group stayed the same level as the normal group.